BETH ISRAEL DEACONESS - PLYMOUTH — History
CCN 220060 | 3-year financial timeline | COVID resilience: 77/100
🛡️ Public data only — no PHI permitted on this instance.
$349M
Latest Revenue (FY2022)
+11.1%
Revenue CAGR (3yr)
2.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $283M | $317M | $349M | +10.1% | +11.1% |
| Operating Expenses | $291M | $318M | $340M | +7.0% | +8.1% |
| Operating Margin | -3.0% | -0.3% | 2.6% | +876.3% | +0.0% |
| Net Income | $-8M | $-1M | $9M | +955.0% | +0.0% |
| Licensed Beds | 145 | 150 | 150 | +0.0% | +1.7% |
| Total Patient Days | 46,500 | 49,431 | 49,800 | +0.7% | +3.5% |
| Medicare Day % | 51% | 51% | 47% | -7.2% | -3.9% |
| Medicaid Day % | 3% | 4% | 7% | +101.4% | +47.1% |
COVID Impact & Recovery
Resilience Score: 77/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +23.5% ($283M → $349M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+11.1%
This Hospital
+7.6%
State Avg
Latest Margin
2.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $382M | 5.3% |
| FY2024 (proj) | $415M | 8.1% |
| FY2025 (proj) | $449M | 10.9% |